| NCT Number | NCT07660003 |
| Lead Sponsor | Kayseri City Hospital |
| Conditions | Febrile Seizures, Oxidative Stress, Oxidative DNA Damage |
| Enrollment | 156 participants |
| Start Date | 2021-09-01 |
| Primary Completion | 2022-06-30 (estimated) |
| Study Completion | 2022-12-30 (estimated) |
| Updated on ClinicalTrials.gov | 2026-07-07 |